Brigitte Witz

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

Francis Witz, Alain Sadoun, M. C. Perrin et al. · PubMed · 1998 · 147 citations

Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study

Éric Solary, Brigitte Witz, Denis Caillot et al. · Blood · 1996 · 114 citations · Full text

Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia

Éric Solary, Bernard Drénou, Lydia Campos et al. · Blood · 2003 · 86 citations · Full text

Granulocyte Colony-Stimulating Factor After Intensive Consolidation Chemotherapy in Acute Myeloid Leukemia: Results of a Randomized Trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques

Jean‐Luc Harousseau, Brigitte Witz, Bruno Lioure et al. · Journal of Clinical Oncology · 2000 · 83 citations

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study

Bruno Lioure, Marie C. Béné, Arnaud Pigneux et al. · Blood · 2012 · 46 citations · Full text